These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39335212)

  • 1. Induction of Invasive Basal Phenotype in Triple-Negative Breast Cancers by Long Noncoding RNA BORG.
    Niazi F; Parker KA; Mason SJ; Singh S; Schiemann WP; Valadkhan S
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells.
    Parker KA; Gooding AJ; Valadkhan S; Schiemann WP
    Mol Cancer Res; 2021 Dec; 19(12):2068-2080. PubMed ID: 34497119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers.
    Tu Z; Schmöllerl J; Cuiffo BG; Karnoub AE
    Stem Cells; 2019 Oct; 37(10):1281-1292. PubMed ID: 31283068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.
    Gooding AJ; Zhang B; Gunawardane L; Beard A; Valadkhan S; Schiemann WP
    Oncogene; 2019 Mar; 38(12):2020-2041. PubMed ID: 30467380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of long noncoding RNA in triple-negative breast cancer.
    Das PK; Siddika A; Rashel KM; Auwal A; Soha K; Rahman MA; Pillai S; Islam F
    Cancer Med; 2023 Oct; 12(20):20365-20379. PubMed ID: 37795578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer.
    Zhao Z; Guo Y; Liu Y; Sun L; Chen B; Wang C; Chen T; Wang Y; Li Y; Dong Q; Ai L; Wang R; Gu Y; Li X
    Oncogene; 2021 Jul; 40(27):4604-4614. PubMed ID: 34131286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SBF2-AS1 and TreRNA: novel lncRNA players in triple-negative breast cancer pathogenesis.
    Kamaliyan Z; Dorraji K; Kakavand S; Azizi-Tabesh G; Mirfakhraie N; Omranipour R; Ahmadinejad N; Yassaee VR; Mirfakhraie R
    Mol Biol Rep; 2023 Jul; 50(7):6029-6037. PubMed ID: 37286777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
    He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
    Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA AFAP1-AS1 is upregulated in metastatic triple-negative breast tumors and controls hypoxia-activated vasculogenic mimicry and angiogenesis.
    García-Hernández AP; Corona DN; Carlos-Reyes Á; Sierra-Martínez M; Acosta-Altamirano G; Cisneros-Villanueva M; Pérez-Navarro Y; Ibarra-Sierra E; Marchat LA; López-Camarillo C
    BMC Cancer; 2024 Oct; 24(1):1332. PubMed ID: 39472818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
    Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
    Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
    Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
    Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer.
    Chen C; Li Z; Yang Y; Xiang T; Song W; Liu S
    Cancer Biol Ther; 2015; 16(6):856-65. PubMed ID: 25996380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis.
    Zhang H; Wang J; Yin Y; Meng Q; Lyu Y
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33443534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer.
    Lv M; Xu P; Wu Y; Huang L; Li W; Lv S; Wu X; Zeng X; Shen R; Jia X; Yin Y; Gu Y; Yuan H; Xie H; Fu Z
    Oncotarget; 2016 Mar; 7(11):13047-59. PubMed ID: 26910840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence.
    Gooding AJ; Zhang B; Jahanbani FK; Gilmore HL; Chang JC; Valadkhan S; Schiemann WP
    Sci Rep; 2017 Oct; 7(1):12698. PubMed ID: 28983112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.